Orexo has a strong history of developing new products approved in markets all over the world. In order to ensure a continued inflow of new improved drugs, the development work at the R&D department in Uppsala, Sweden, has intensified. Filling an unmet need among healthcare professionals and patients is the key in the work of developing new innovative products for treatment of opioid addiction in all phases.
To follow all development phases for the products/projects, please use the scroll function in the bottom of this image. To read about each development project please go to the main menu Pipeline and its sub-menu.